Oct 22 (Reuters) - Genscript Biotech Corp :
* VARIATION OF DEPOSIT AGREEMENT RESULTING IN DECONSOLIDATION OF LEGEND BIOTECH CORPORATION AND ITS SUBSIDIARIES
* EXPECTS DECONSOLIDATION TO HAVE SIGNIFICANT IMPACT ON CONSOLIDATED FINANCIAL STATEMENTS OF GROUP FOR FY2024
* EXPECTED SIGNIFICANT AMOUNT OF GAIN WILL BE RECOGNIZED UPON DECONSOLIDATION
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments